Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSPA8 | P11142 | 3/20 | 0.80 |
| ▸ | HSPA5 | P11021 | 2/20 | 0.80 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.76 |
| ▸ | GAPDH | P04406 | 3/20 | 0.69 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.68 |
| ▸ | LMNA | P02545 | 1/20 | 0.68 |
| ▸ | TP53 | P04637 | 1/20 | 0.68 |
| ▸ | HBB | P68871 | 1/20 | 0.68 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.64 |
| ▸ | ADK | P55263 | 1/20 | 0.64 |
| ▸ | AMD1 | P17707 | 1/20 | 0.64 |
| ▸ | SLC28A2 | O43868 | 2/20 | 0.63 |
| ▸ | DPP4 | P27487 | 1/20 | 0.63 |
| ▸ | MEN1 | O00255 | 1/20 | 0.63 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.63 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.63 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.63 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4126993 | 1.00 | HSPA8 (0.80) | HSPA8HSPA5RXFP1GAPDHHSD17B10 | |
| SCHEMBL1145052 | 0.89 | HSPA8 (1.00) | HSPA8HSPA5RXFP1GAPDHHSD17B10 | |
| SCHEMBL17412455 | 0.89 | HSPA8 (1.00) | HSPA8HSPA5RXFP1GAPDHHSD17B10 | |
| SCHEMBL1145049 | 0.89 | HSPA8 (1.00) | HSPA8HSPA5RXFP1GAPDHHSD17B10 | |
| SCHEMBL6305168 | 0.88 | HSPA8 (0.80) | HSPA8HSPA5RXFP1GAPDHHSD17B10 | |
| SCHEMBL18858928 | 0.88 | HSPA8 (0.80) | HSPA8HSPA5RXFP1GAPDHHSD17B10 | |
| SCHEMBL15906300 | 0.88 | HSPA8 (0.80) | HSPA8HSPA5RXFP1GAPDHHSD17B10 | |
| SCHEMBL1135195 | 0.88 | HSPA8 (0.80) | HSPA8HSPA5RXFP1GAPDHHSD17B10 | |
| SCHEMBL5362344 | 0.88 | HSPA8 (0.80) | HSPA8HSPA5RXFP1GAPDHHSD17B10 | |
| SCHEMBL15906323 | 0.88 | HSPA8 (0.80) | HSPA8HSPA5RXFP1GAPDHHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121678872-A | Method for detecting iodo-nucleoside in drinking water by solid phase extraction-vacuum centrifugal concentration-liquid chromatography tandem mass spectrometry | 浙江大学 | 2026-03-17 | — | — | CN | disclosed |
| US-8946188-B2 | Anti-microbial agents and uses thereof | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2015-02-03 | — | — | US | disclosed |
| WO-2014128289-A1 | BIOMEDICAL DEVICE IMPLANTABLE IN BONE AND/OR CARTILAGINOUS TISSUE, AND CORRESPONDING METHOD TO MANUFACTURE SAID BIOMEDICAL DEVICE | LUMETTI, SIMONE (IT) | 2014-08-28 | — | — | WO | disclosed |
| US-20140024611-A1 | ANTI-MICROBIAL AGENTS AND USES THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2014-01-23 | — | — | US | disclosed |
| US-8461128-B2 | Anti-microbial agents and uses thereof | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2013-06-11 | — | — | US | disclosed |
| US-20090170805-A1 | ANTI-MICROBIAL AGENTS AND USES THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-07-02 | — | — | US | disclosed |
| WO-2006113615-A2 | ANTI-MICROBIAL AGENTS AND USES THEREOF | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2006-10-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140024611-A1 | ANTI-MICROBIAL AGENTS AND USES THEREOF | ACAT1, ACAT2, APEH | HSPA8 513/4885HSPA5 1808/4885RXFP1 1943/4885 |
| US-20090170805-A1 | ANTI-MICROBIAL AGENTS AND USES THEREOF | ACAT1, ACAT2, APEH | HSPA8 513/4885HSPA5 1808/4885RXFP1 1943/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.